Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>CD33+*** > Treatment > Co: USA. P. GemtuzuMAb Ozogamicin
Co: USA. P. GemtuzuMAb Ozogamicin's subsections
(*) USA Approval Date: 2017. 09.01
Adults & Children 2 Years & Older
Company
Lower Dose Than in Previous 2000>
Patent>Expired
TradeMark
TradeMark Web-Site
Co: USA. P. GemtuzuMAb Ozogamicin's products
This section has no products